Influence of chicken genotype on protection against Marek's disease by a herpesvirus of turkeys recombinant expressing the glycoprotein B (gB) of Marek's disease virus

Vaccine

Volumn 14, Issue 3, 1996, Pages 187-189

  Ross, N ^a   O'Sullivan, G ^a   Coudert, F ^b  

^a INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^b CEMAGREF   (France)

Author keywords

chicken genotype; Marek's disease; recombinant vaccine

Indexed keywords

GLYCOPROTEIN B; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VACCINE;

ANIMAL EXPERIMENT; ARTICLE; AVIAN LYMPHOMATOSIS HERPETOVIRUS; CHICKEN; HAPLOTYPE; HOST RESISTANCE; IMMUNIZATION; INTRAMUSCULAR DRUG ADMINISTRATION; LYMPHOPROLIFERATIVE DISEASE; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; TURKEY (BIRD);

EID: 0029914436     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(95)00215-M     Document Type: Article

References (15)

1. Churchill, A.E., Payne, L.N. and Chubb, R.C. Immunization against Marek's disease using a live attenuated virus. Nature 1969, 22, 744-747
2. von Bulow, V. and Biggs, P.M. Differentiation between strains of Marek's disease virus and turkey herpesvirus by immunofluorescence assays. Avian Pathol. 1975, 4, 133-146
3. Okazaki, W., Purchase, H.G. and Burmester, B.R. Protection against Marek's disease by vaccination with a herpesvirus of turkeys. Avian Dis. 1970, 14, 413-429
4. Briles, W.E., Stone, H.A. and Cole, R.K. Marek's disease: effects of B histocompatibility alloalleles in resistant and susceptible chicken lines. Science 1977, 195, 193-195
5. Witter, R.W. and Fadly, A.M. Characteristics of some selected Marek's disease virus field isolates. In: Resistance and Immunity to Marek's Disease (Ed. Biggs, P.M.). CEC Publication 1980, EUR 6470, pp. 181-191
6. Eidson, C.S., Ellis, M.N. and Kleven, S.H. Reduced vaccinal protection of turkey herpesvirus against field strains of Marek's disease herpesvirus. Poultry Sci. 1981, 60, 317-322
7. Witter, R.L., Sharma, J.M., Lee, L.F., Optiz, H.M. and Henry, C.W. Field trials to test the efficacy of polyvalent Marek's disease vaccines in broilers. Avian Dis. 1984, 28, 44-60
8. Calnek, B.W., Schat, K.A., Peckam, M.C. and Fabricant, J. Field trials with a bivalent vaccine (HVT and SB1) against Marek's disease. Avian Dis. 1983, 27, 844-849
9. Bacon, L.D. and Witter, R.W. Influence of B haplotype on the relative efficacy of Marek's disease vaccines of different serotypes. Avian Dis. 1993, 37, 53-59
10. Nazerian, K., Lee, L.F., Yanagida, N. and Ogawa, R. Protection against Marek's disease by a fowlpox virus recombinant expressing the glycoprotein B of Marek's disease virus. J. Virol. 1992, 66, 1409-1413
11. Ross, L.J.N., Binns, M.M., Tyers, P., Pastorek, J., Zelnik, V. and Scott, S. Construction and properties of a turkey herpesvirus recombinant expressing the Marek's disease virus homologue of glycoprotein B of herpes simplex virus. J. Gen. Virol. 1993, 74, 371-377
12. Silva, R.F. and Lee, L.F. Monoclonal antibody mediated immunoprecipitation of proteins from cells infected with Marek's disease virus or herpesvirus of turkeys. Virology 1984, 136, 307-320
13. β B-F and B-G probes, Immunogenetics 1989, 29, 127-130
14. Schat, K.A., Calnek, B.W. and Fabricant, J. Characterization of two highly oncogenic strains of Marek's disease virus. Avian Pathol. 1982, 11, 593-605
15. Yoshida, S., Lee, L.F., Yanagida, N. and Nazerian, K. The glycoprotein B genes of Marek's disease virus serotypes 2 and 3: identification and expression by recombinant fowlpox viruses. Virology 1994, 200, 484-493